OUR FACILITY

Today’s pharmaceutical obligations in terms of quality and capabilities are decisive for industry players. TOWA answers to these necessities by coming up with a wide range of services in line with market’s requirements. Our premium positioning on the pharmaceutical market place comes from our development and production processes expertise.

State of the Art Facility
  • 22,000 m² manufacturing facility
  • 45,000 m² site
  • Close to Ahmedabad, Gujarat, India.
Pilot Plant
  • Scale-up
  • Industrial scale reproduction
  • Trouble shooting
High Tech Equipment
  • Two integrated granulation lines (450 litres and 1200 litres)
  • Wet Granulation & Fluid Bed Drying (including ethanol and nitrogen)
  • Dry granulation (Roller compactor)
  • 4 compression suites able to manufacture single, 2-layer and 3-layer tablets
  • Vented Side Pan Coater
  • Capsule filling (powder and tabs in capsule)
Facility Capabilities
  • Pilot scale materials for products
  • Scale up production from Phase III Clinical Trial Materials
  • Batches validation, Samples and Commercial products
cGMP Status

TOWA’s site is complying with :

  • EU GMP
  • PIC/S
  • US (FDA)
  • MHRA, UK
  • ANVISA, Brazil
  • TGA, Australia
  • TFDA, Tanzania
  • NAFDEC, Nigeria

Thanks to our internationally recognized Indian expertise, we design, develop, produce and register files of pharmacologically proven formulated molecules with the American (FDA) European (EMA) and national (ANSM) drug agencies. To offer the best services, we commercialise them according to the quality standards known as Good Manufacturing Practices (GMP or cGMP). The pharmaceutical companies we work with are very demanding. For the battle they are leading is just as demanding.